Windlas Biotech Limited (NSE:WINDLAS)
India · Delayed Price · Currency is INR 830.00
+4.10 (0.50%)
Jul 10, 2026, 3:30 PM IST
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 17.13 billion as of July 10, 2026. Its market cap has decreased by -6.77% in one year.
Market Cap
17.13B
Enterprise Value
14.69B
Revenue
9.04B
Ranking
n/a
PE Ratio
26.64
Stock Price
830.00
Market Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 17.13B, an increase of 93.01%. That is a compound annual growth rate of 14.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 17.13B | 2.78% |
| Dec 31, 2025 | 16.66B | -23.42% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
| Aug 16, 2021 | 8.87B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 56.62B |
| Orchid Pharma | 51.36B |
| RPG Life Sciences | 47.25B |
| Solara Active Pharma Sciences | 27.41B |
| Indoco Remedies | 24.02B |
| Beta Drugs | 23.89B |
| Ind-Swift Laboratories | 21.37B |
| Sakar Healthcare | 18.35B |